Province Expands Access to Chronic Obstructive Pulmonary Disease Inhalers
The province has announced that long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease, are now open benefits for beneficiaries of the Newfoundland and Labrador Prescription Drug Program (NLPDP) effective June 14. Chronic Obstructive Pulmonary Disease (COPD) is a debilitating lung disease that results in severe progressive airway dysfunction. Patients […]
Read more